research Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.
Mysuru, Karnataka, India
Coimbatore, Tamil Nadu, India
Satara, Maharashtra, India
Jakarta, Indonesia



